UK-Style Insurance Risk-Sharing Could Affect Medicaid Rebates, Part B ASPs
Executive Summary
U.S. biopharma manufacturers should be cautious about importing the British National Institute for Health and Clinical Excellence's approaches to reimbursement risk-sharing, as such schemes could have unanticipated consequences for obligations such as Medicaid rebates